CASI Pharmaceuticals (CASI) Total Assets by Year
CASI Pharmaceuticals, Inc. closed fiscal year 2025 with $25.6M in total assets, $62.9M in total liabilities and -$37.3M in shareholder equity. Total assets fell 52.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters CASI Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CASI Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
CASI Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More CASI Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was CASI Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
CASI Pharmaceuticals, Inc. closed fiscal year 2025 with $25.6M in total assets, $62.9M in total liabilities and -$37.3M in shareholder equity.
How fast is CASI Pharmaceuticals, Inc.'s total assets growing?
CASI Pharmaceuticals, Inc. (CASI) total assets fell by 52.2% year over year, from $53.7M to $25.6M in fiscal year 2025.
What was CASI Pharmaceuticals, Inc.'s total assets in the most recent quarter?
CASI Pharmaceuticals, Inc. (CASI) reported $25.6M in total assets in Q4 2025. This represents a decrease of 52.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what CASI Pharmaceuticals, Inc. (CASI) reported on that line in every period on record.